Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 2/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12879484 | 0.79 | CYP1A2 (0.36) | SHBGCYP1A2 | |
| Formic Acid SCHEMBL28202929 | 0.79 | ADH1A (0.36) | ADH1AADH1C | |
| SCHEMBL28290050 | 0.78 | SHBG (0.35) | SHBGADH1AADH1CCYP1A2 | |
| SCHEMBL8487418 | 0.76 | — | — | |
| SCHEMBL22006126 | 0.76 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL17565668 | 0.75 | CYP1A2 (0.43) | CYP1A2 | |
| SCHEMBL10401332 | 0.74 | SHBG (0.36) | SHBGADH1AADH1CCYP1A2 | |
| SCHEMBL3889883 | 0.74 | SHBG (0.36) | SHBGADH1AADH1CCYP1A2 | |
| SCHEMBL7737955 | 0.74 | SHBG (0.36) | SHBGADH1AADH1CCYP1A2 | |
| SCHEMBL7733138 | 0.74 | SHBG (0.36) | SHBGADH1AADH1CCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109641482-A | The preparation of the cis- -1,4- polydiene of multiple silane functionals with the Si―H addition reaction in situ preparation by polymer glue | 株式会社普利司通 | 2019-04-16 | — | — | CN | disclosed |
| US-8729195-B2 | Organosilicon compound, method for producing thereof, and curable silicone composition containing the same | DOW CORNING TORAY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729195-B2 | Organosilicon compound, method for producing thereof, and curable silicone composition containing the same | DOW CORNING TORAY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20120309921-A1 | Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same | DOW CORNING TORAY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| CN-1713787-A | Organic electroluminescent device, method for producing the same, and electronic apparatus | SEIKO EPSON CORP (JP) | 2005-12-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309921-A1 | Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same | SRM, ESD, THEM6 | SHBG 3464/4885ADH1A 2414/4885ADH1C 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.